Trial Search Results
Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA
The primary objective is to determine if pre-operative transversus abdominis plane (TAP) nerve blocks by continued infusion of local anesthetic post-operatively affects post-operative narcotic usage, as compared to a placebo TAP block, after breast reconstruction surgery.
Stanford is currently not accepting patients for this trial.
- Procedure: Transversus Abdominis Plane (TAP) block
- Device: Nimbus Infusion Pump IV Administration
- Drug: Bupivacaine infusion
- Drug: Acetominophen
- Drug: Hydromorphone
- Drug: Oxycodone
- Drug: Ondansetron
- Prior diagnosis or presumed diagnosis of breast cancer or undergoing prophylactic
- Greater than 18 years old.
- Undergoing microsurgical breast reconstruction with abdominal free flap.
- Ability to understand and the willingness to sign a written informed consent document.
- True allergy to local anesthetics or opioids.
- History of addiction to narcotics within the last 24 months
- History of chronic pain on opioids within the last 24 months.
- Specific mental health issues such as schizophrenia or bipolar disorder.
- Patients who are pregnant.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study